Common Data Elements in Radiologic Imaging of Traumatic Brain Injury

Massachusetts General Hospital, Boston, USA.
Archives of physical medicine and rehabilitation (Impact Factor: 2.18). 11/2010; 91(11):1661-6. DOI: 10.1016/j.apmr.2010.07.238
Source: PubMed

ABSTRACT Radiologic brain imaging is the most useful means of visualizing and categorizing the location, nature, and degree of damage to the central nervous system sustained by patients with traumatic brain injury (TBI). In addition to determining acute patient management and prognosis, imaging is crucial for the characterization and classification of injuries for natural history studies and clinical trials. This article is the initial result of a workshop convened by multiple national health care agencies in March 2009 to begin to make recommendations for potential data elements dealing with specific radiologic features and definitions needed to characterize injuries, as well as specific techniques and parameters needed to optimize radiologic data acquisition. The neuroimaging work group included professionals with expertise in basic imaging research and physics, clinical neuroradiology, neurosurgery, neurology, physiatry, psychiatry, TBI research, and research database formation. This article outlines the rationale and overview of their specific recommendations. In addition, we review the contributions of various imaging modalities to the understanding of TBI and the general principles needed for database flexibility and evolution over time to accommodate technical advances.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Glial Fibrillary Acidic Protein and its breakdown products (GFAP-BDP) are brain specific proteins released into serum as part of the pathophysiologic response following traumatic brain injury (TBI). We performed a multicenter trial to validate and characterize the use of GFAP-BDP levels in the diagnosis of intracranial injury in a broad population of patients with a positive clinical screen for head injury. This multicenter, prospective cohort study included patients 16 to 93 years old presenting to 3 Level I trauma centers with suspected TBI (loss of consciousness, post-trauma amnesia, etc.). Serum GFAP-BDP levels were drawn within 24 hours and analyzed, in a blinded fashion, using sandwich enzyme-linked immunosorbent assay. The ability of GFAP-BDP to predict intracranial injury on admission CT as well as delayed MRI was analyzed by multiple regression and assessed by the area under the receiver operating characteristic curve (AUC). Utility of GFAP-BDP to predict injury and reduce unnecessary CT scans was assessed utilizing decision curve analysis. 215 patients were included, of which 83% suffered mild TBI, 4% moderate, and 12% severe; the mean age was 42.1± 18 years. Evidence of intracranial injury was present in 51% of the sample (median Rotterdam Score 2 (IQR 2)). GFAP-BDP demonstrated very good predictive ability (AUC= 0.87), and demonstrated significant discrimination of injury severity (OR 1.45, 95% CI 1.29-1.64). Use of GFAP-BDP yielded a net benefit above clinical screening alone and a net reduction in unnecessary scans by 12 to 30%. Used in conjunction with other clinical information, rapid measurement of GFAP-BDP is useful in establishing or excluding the diagnosis of radiographically apparent intracranial injury throughout the spectrum of TBI. As an adjunct to current screening practices, GFAP-BDP may help avoid unnecessary CT scans without sacrificing sensitivity.
    Journal of Neurotrauma 09/2014; DOI:10.1089/neu.2014.3635 · 3.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Although the majority of patients with mild traumatic brain injury (mTBI) recover completely, some still suffer from disabling ailments at 3 or 6 months. We validated existing prognostic models for mTBI, and explored predictors of poor outcome after mTBI. Methods We selected patients with mTBI from TRACK-TBI Pilot; an unselected observational cohort of TBI patients from three centers in the United States. We validated two prognostic models for the Glasgow Outcome Scale Extended (GOS-E) at 6 months after injury. One model was based on the CRASH study data, and another from Nijmegen, the Netherlands. Possible predictors of 3 and 6-month GOS-E were analyzed with univariate and multivariable proportional odds regression models. Results Of the 386 out of 485 patients included in the study (median age 44 years (interquartile range: 27-58)), 75% (n=290) presented with a Glasgow Coma Score (GCS) of 15. In this mTBI population both previously developed models had a poor performance (AUC 0.49 to 0.56). In multivariable analyses, the strongest predictors of lower 3 and 6-month GOS-E were older age, pre-existing psychiatric conditions and lower education. Injury caused by assault, extracranial injuries and lower GCS were also predictive of lower GOS-E. Conclusion Existing models for mTBI performed unsatisfactorily. Our study shows that for mTBI different predictors are relevant as for moderate and severe TBI. These include age, pre-existing psychiatric conditions and lower education. Development of a valid prediction model for mTBI patients requires further research efforts.
    Journal of Neurotrauma 07/2014; 32(2). DOI:10.1089/neu.2014.3384 · 3.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: We evaluated 3-Tesla diffusion tensor imaging (DTI) for white matter injury in 76 adult mild traumatic brain injury (mTBI) patients at the semi-acute stage (11.2±3.3 days), employing both whole-brain voxelwise and region-of-interest (ROI) approaches. The subgroup of 32 patients with any traumatic intracranial lesion on day-of-injury CT or semi-acute MRI demonstrated reduced fractional anisotropy (FA) in numerous white matter tracts, compared to 50 control subjects. In contrast, 44 CT/MRI negative mTBI patients demonstrated no significant difference in any DTI parameter compared to the controls. To determine the clinical relevance of DTI, we evaluated correlations between 3- and 6-month outcome measures and imaging, demographic/socioeconomic and clinical predictors. Statistically significant univariable predictors of 3-month Glasgow Outcome Scale-Extended (GOS-E) included MRI evidence for contusion (odds ratio (OR) 4.9 per unit decrease in GOS-E, p=0.01), ≥1 ROI with severely reduced FA (OR 3.9, p=0.005), neuropsychiatric history (OR 3.3, p=0.02), age (OR 1.07/year, p=0.002), and years of education (OR 0.79/year, p=0.01). Statistically significant predictors of 6-month GOS-E included ≥1 ROI with severely reduced FA (OR 2.7, p=0.048), neuropsychiatric history (OR 3.7, p=0.01), and education (OR 0.82/year, p=0.03). For the subset of 37 patients lacking neuropsychiatric/substance abuse history, MRI surpassed all other predictors for both 3- and 6-month outcome prediction. This is the first study to compare DTI in individual mTBI patients to conventional imaging, clinical, and demographic/socioeconomic characteristics for outcome prediction. DTI demonstrated utility in an inclusive group of patients with heterogeneous backgrounds, as well as in a subset of patients without neuropsychiatric/substance abuse history.
    Journal of neurotrauma 04/2014; 31(17). DOI:10.1089/neu.2013.3171 · 4.25 Impact Factor